A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome

Clinical trial NCT06312020 · TERMINATED

Trial details

NCT number: NCT06312020
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Sjogren's Syndrome

Start date: 2024-05-09
Primary completion: 2026-04-28
Enrollment: 209

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.